Esteban Rodrigo Imedio

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Combination Therapy

Peritoneal Dialysis

Papillary Thyroid

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Targeted oncology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Todd M Bauer, Kathleen M Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Sarah A Cook, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Siqing Fu
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology (2023)
Gerald S Falchook, Jasgit C Sachdev, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Melissa Lynne Johnson
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors. Investigational new drugs (2023)
Kathleen M Moore, Setsuko K Chambers, Erika P Hamilton, Lee-May Chen, Amit M Oza, Sharad A Ghamande, Gottfried E Konecny, Steven C Plaxe, Daniel L Spitz, Jill J J Geenen, Tiffany A Troso-Sandoval, Janiel M Cragun, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Zhongwu Lai, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Karen A Cadoo
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)